Our Blog Analyses, news and events

Seminar: General victimology, torture and organized violence

DIGNITY – Danish Institute Against Torture invites to a one day seminar on General victimology, torture and organized violence: Theory, methodology and practice on 20 October 2015. The seminar is open to all academics and practitioners who are interested in victims, victimization and victimology. Participation of the students is encouraged.

Read more about the seminar on DIGNITY’s homepage.

read more

Link: A new Lancet Commission on SRHR

The Guttmacher Institute and The Lancet are establishing a Commission on sexual and reproductive health and rights in the post-2015 world, writes Ann Starr, President and CEO of the Guttmacher Institute in her comment titled: A Lancet Commission on sexual and reproductive health and rights: going beyond the Sustainable Development Goals on www.thelancet.com.

The Commission will begin work in early 2016 with the aim of developing a wide-ranging and evidence-based agenda for key sexual and reproductive health and rights priorities worldwide over the next 15 years.

read more

ADB-2015-09-22-11.07.28.jpg

ADB visiting Denmark, health on agenda

The Asian Development Bank (ADB) is visiting Denmark and together the Ministry of Foreign Affairs are organising a seminar: Business Opportunities with Asian Development Bank on 24 September 2015. The seminar aims to inform Danish companies about opportunities for involvement in ADB financed projects. The seminar has a special focus on two specific sectors: health and clean energy.

Below you will find some of the background material used in the seminar:

  • A Prezi-presentation on the ADB’s new vision for health in 2015-2020 by Dr Susan Roth, Senior Social Development Specialist from the health sector group secretariat.
  • Briefing Paper: Health in Asia and the Pacific: In Brief

read more

dips2012-vandret.png

8th Danish Paediatric Infectious Diseases Symposium

The Danish Society for Paediatric Infectious Diseases (DIPS) is organising an international symposium on 2-3 October 2015 at Comwell Klarskovgaard, Korsør. The scientific programme, and registration form can be found at DIPS’s homepage.

Established in October 2011, DIPS is a society for Paediatricians, Physicians, Academics and other healthcare personal who have an interest in Paediatric Infectious Diseases (PID). The purpose of the society is to promote education and research related to PID.

read more

Link: African scientists’ fight for equality

An article at www.nature.com titled After years of second-class status in research partnerships, African scientists are calling for change by Linda Nordling, discusses the important issue of equality in research.

The Nairobi Industrial Court agreed that six Kenyan doctors in an international research partnership had been systematically passed over for promotion and training, whereas their European colleagues had flourished. It was also perhaps the first time that African researchers had so strongly — and so publicly — voiced resentment of their perceived second-class status in partnerships with foreign colleagues. African scientists say that they often feel stuck in positions such as data-collectors and laboratory technicians, with no realistic path to develop into leaders.

Read the article Africa’s fight for equality.

read more

Logo-e1432550286249.jpg

GHM Annual Meeting 2015

Join us for the Global Health Minders’ Annual Meeting Wednesday 24 June 2015 at 10.00-12.00.

The meeting will be held at the University of Copenhagen, Department of Anthropology, Meeting room 16.0.30 (Building 16, ground floor, room 30), CSS, Øster Farimagsgade 5.

Please let us know if you will attend the meeting by email to no later than Monday 22 June.

read more

Drugs-on-shelf-2006.jpg

GHM Controversial Issue Brief: Big Pharma

In the GHM Controversial Issue Brief titled ‘How can we collaborate with Big Pharma in global health?‘, Nicolai Lohse writes:

The combination of pharmaceutical companies and global health invariably makes one think of the huge lack of access to medicine in low- and middle-income countries (LMIC). Drugs are either not affordable, not available at all, only available intermittently due to frequent pharmacy stock-outs, of poor quality, ineffective, or they are counterfeit and may even be unsafe.

 

Making quality medicine available, affordable, and accessible to all who need them is extremely complicated and requires a coordinated effort by many global health actors – including the pharmaceutical industry. In this need for collaborative solutions lies also the key to involving drug companies as a partner in global health.

Download the brief on Big Pharma.

Photo credit: Erling Høg

read more